Sunday, March 02, 2025 10:04:15 PM
On more than one occasion I've voiced the fact that lending the shares gives me the option to pull them when I feel the time is right. I've expressed it as a way NWBO investors can both make money, and help to make the squeeze worse for the shorts. Right now Fidelity won't allow me to put a buy on the stock at a price I'd consider to help in a squeeze, but I believe once we're into the $1 to $2 range they will. I'm fine with the criticism, but I have previously mentioned this strategy.
I would suspect that many here may have their shares being borrowed without making anything, and without knowing it. I know it, I know they're not borrowing all the shares they could, and I welcome the thousands I've seen from it, it permitted the purchase of additional shares.
I'll repeat my belief that the shares known to be outstanding shorts is far from the total shorts. Those we know of aren't nearly as damaging as what's hidden by the MM's and their manipulation.
I look forward to when I can routinely set trailing stop loss orders, but not until we're trading around $10 or more.
A fraction of my shares has permitted me to add roughly 8,000 shares a month, frankly if they took more shares I wouldn't mind as I'd just buy more.
Gary
I would suspect that many here may have their shares being borrowed without making anything, and without knowing it. I know it, I know they're not borrowing all the shares they could, and I welcome the thousands I've seen from it, it permitted the purchase of additional shares.
I'll repeat my belief that the shares known to be outstanding shorts is far from the total shorts. Those we know of aren't nearly as damaging as what's hidden by the MM's and their manipulation.
I look forward to when I can routinely set trailing stop loss orders, but not until we're trading around $10 or more.
A fraction of my shares has permitted me to add roughly 8,000 shares a month, frankly if they took more shares I wouldn't mind as I'd just buy more.
Gary
Bullish
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
